Christy J. Oliger - 07 Jun 2024 Form 4 Insider Report for Vera Therapeutics, Inc. (VERA)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	VERA	Stock Option (right to buy)	Award	$0	+25,000		$0.000000	25,000	07 Jun 2024	Class A Common Stock	25,000	$38.50	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	The shares subject to the option will vest monthly over a three-year period, subject to the Reporting Person's continuous service on each vesting date.